100 related articles for article (PubMed ID: 6984418)
1. Immunosuppressive effect of cyclosporin A in two lymphocyte transfer models in rats: comparison of in vivo and in vitro treatment.
Ryffel B; Feurer C; Heuberger B; Borel JF
Immunobiology; 1982 Dec; 163(5):470-83. PubMed ID: 6984418
[TBL] [Abstract][Full Text] [Related]
2. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
Wegmann KW; Hinrichs DJ
J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune effector cells. I. Transfer of experimental encephalomyelitis with lymphoid cells cultured with antigen.
Holda JH; Welch AM; Swanborg RH
Eur J Immunol; 1980 Aug; 10(8):657-9. PubMed ID: 6967418
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
[TBL] [Abstract][Full Text] [Related]
5. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
6. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
Bolton C; Allsopp G; Cuzner ML
Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543
[TBL] [Abstract][Full Text] [Related]
7. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis.
Ellerman KE; Powers JM; Brostoff SW
Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505
[TBL] [Abstract][Full Text] [Related]
8. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
Hinrichs DJ; Roberts CM; Waxman FJ
J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
12. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
Panitch HS; McFarlin DE
J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.
Hayosh NS; Simon LL; Swanborg RH
J Immunol; 1984 Oct; 133(4):1943-5. PubMed ID: 6236261
[TBL] [Abstract][Full Text] [Related]
14. Comparison of potentiality to induce graft-versus-host reaction with small bowel, pancreas/spleen, and liver transplantation in the rat.
Kobayashi E; Kamada N; Enosawa S; Toyama N; Delriviere L; Goto S; Kim YI; Miyata M
Clin Exp Immunol; 1993 Jun; 92(3):527-31. PubMed ID: 8513585
[TBL] [Abstract][Full Text] [Related]
15. Modulation by cyclosporin-A of mononuclear cell distribution during experimental allergic encephalomyelitis.
Rumjanek VM; Smith LA; Morley J
Int J Immunopharmacol; 1984; 6(2):99-104. PubMed ID: 6610655
[TBL] [Abstract][Full Text] [Related]
16. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
Holda JH; Silberg D; Swanborg RH
J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
Whitacre CC; Gienapp IE; Orosz CG; Bitar DM
J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
